In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Hologic buys BioLucent for $70mm plus earnout

Executive Summary

Hologic (diagnostics and medical imaging systems) has bought BioLucent (women's health products) including its MammoPad breast cushion business unit for $70mm--consisting of $5mm in cash plus $65mm in cash, Hologic common shares, or a combination of the two--and a two-year revenue-based earnout that could result in two annual cash payments of up to $15mm each.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Includes Earnout
    • Payment Includes Cash
    • Payment Includes Stock

Related Companies